Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment

被引:31
作者
Cai, Qingqing [1 ]
Fang, Yu [1 ]
Young, Ken H. [2 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, 1515 Holcombe Blvd, Houston, TX 77030 USA
基金
中国国家自然科学基金;
关键词
PRIMARY CNS LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; WHOLE-BRAIN RADIOTHERAPY; STEM-CELL TRANSPLANTATION; INTERNATIONAL EXTRANODAL LYMPHOMA; RECURRENT PRIMARY CNS; UNDER-THE-CURVE; SALVAGE THERAPY; INTENSIVE CHEMOTHERAPY; 1ST-LINE TREATMENT;
D O I
10.1016/j.tranon.2018.11.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary central nervous system lymphoma (PCNSL) is a group of extranodal non-Hodgkin lymphoma that exhibits specific biological characteristics and clinical behavior, with an aggressive disease course and unsatisfactory patient outcomes. It is of great importance to identify aberrant genetic loci and important molecular pathways that might suggest potential targets for new therapeutics and provide prognostic information. In this review, we listed various genetic and epigenetic alterations that are involved in PCNSL pathogenesis. In the aspect of treatment, we summarized the related literatures and evaluated the efficacy of surgery, induction chemotherapy, radiotherapy, intrathecal chemotherapy, and autologous stem cell transplantation in PCNSL. We also proposed the possible new agents for recurrent and relapse PCNSL based on the result of recent clinical researches.
引用
收藏
页码:523 / 538
页数:16
相关论文
共 139 条
[31]   Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide [J].
Enting, RH ;
Demopoulos, A ;
DeAngelis, LM ;
Abrey, LE .
NEUROLOGY, 2004, 63 (05) :901-903
[32]   Primary lymphoma of the central nervous system: Typical and atypical CT and MR imaging appearances [J].
Erdag, N ;
Bhorade, RM ;
Alberico, RA ;
Yousuf, N ;
Patel, MR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (05) :1319-1326
[33]   Prognostic scoring system for primary CNS lymphomas: The international extranodal lymphoma study group experience [J].
Ferreri, AJM ;
Blay, JY ;
Reni, M ;
Pasini, F ;
Spina, M ;
Ambrosetti, A ;
Calderoni, A ;
Rossi, A ;
Vavassori, V ;
Conconi, A ;
Devizzi, L ;
Berger, F ;
Ponzoni, M ;
Borisch, B ;
Tinguely, M ;
Cerati, M ;
Milani, M ;
Orvieto, E ;
Sanchez, J ;
Chevreau, C ;
Dell'Oro, S ;
Zucca, E ;
Cavalli, F .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :266-272
[34]   A multicenter study of treatment of primary CNS lymphoma [J].
Ferreri, AJM ;
Reni, M ;
Pasini, F ;
Calderoni, A ;
Tirelli, U ;
Pivnik, A ;
Aondio, GM ;
Ferrarese, F ;
Gomez, H ;
Ponzoni, M ;
Borisch, B ;
Berger, F ;
Chassagne, C ;
Iuzzolino, P ;
Carbone, A ;
Weis, J ;
Pedrinis, E ;
Motta, T ;
Jouvet, A ;
Barbui, T ;
Cavalli, F ;
Blay, JY .
NEUROLOGY, 2002, 58 (10) :1513-1520
[35]   Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas [J].
Ferreri, AJM ;
Guerra, E ;
Regazzi, M ;
Pasini, F ;
Arnbrosetti, A ;
Pivnik, A ;
Gubkin, A ;
Calderoni, A ;
Spina, M ;
Brandes, A ;
Ferrarese, F ;
Rognone, A ;
Govi, S ;
Dell'Oro, S ;
Locatelli, M ;
Villa, E ;
Reni, M .
BRITISH JOURNAL OF CANCER, 2004, 90 (02) :353-358
[36]   Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial [J].
Ferreri, Andres J. M. ;
Cwynarski, Kate ;
Pulczynski, Elko ;
Ponzoni, Mourilio ;
Deckert, Martina ;
Politi, Letterio S. ;
Torri, Valter ;
Fox, Christopher P. ;
La Rosee, Paul ;
Schorb, Elisabeth ;
Ambrosetti, Achille ;
Roth, Alexander ;
Hemmoway, Claire ;
Ferrari, Angela ;
Linton, Kim M. ;
Ruda, Roberta ;
Binder, Mascha ;
Pukrop, Tobias ;
Balzarotti, Monica ;
Fabbri, Alberto ;
Johnson, Peter ;
Gorlov, Jette Sonderskov ;
Hess, Georg ;
Panse, Jens ;
Pisani, Francesco ;
Tucci, Alessandra ;
Stilgenbauer, Stephan ;
Hertenstein, Bernd ;
Keller, Ulrich ;
Krause, Stefan W. ;
Levis, Alessandro ;
Schmoll, Hans J. ;
Covalli, Franco ;
Finke, Jurgen ;
Reni, Michele ;
Zucca, Emanuele ;
Illerhaus, Gerald .
LANCET HAEMATOLOGY, 2016, 3 (05) :E217-E227
[37]   High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial [J].
Ferreri, Andres J. M. ;
Reni, Michele ;
Foppoli, Marco ;
Martelli, Maurizio ;
Pangalis, Gerasimus A. ;
Frezzato, Maurizio ;
Cabras, Maria Giuseppina ;
Fabbri, Alberto ;
Corazzelli, Gaetano ;
Ilariucci, Fiorella ;
Rossi, Giuseppe ;
Soffietti, Riccardo ;
Stelitano, Caterina ;
Vallisa, Daniele ;
Zaja, Francesco ;
Zoppegno, Lucia ;
Aondio, Gian Marco ;
Avvisati, Giuseppe ;
Balzarotti, Monica ;
Brandes, Alba A. ;
Fajardo, Jose ;
Gomez, Henry ;
Guarini, Attilio ;
Pinotti, Graziella ;
Rigacci, Luigi ;
Uhlmann, Catrina ;
Picozzi, Piero ;
Vezzulli, Paolo ;
Ponzoni, Maurilio ;
Zucca, Emanuele ;
Caligaris-Cappio, Federico ;
Cavalli, Franco .
LANCET, 2009, 374 (9700) :1512-1520
[38]   Prospective trial on topotecan salvage therapy in primary CNS lymphoma [J].
Fischer, L. ;
Thiel, E. ;
Klasen, H. -A. ;
Birkmann, J. ;
Jahnke, K. ;
Martus, P. ;
Korfel, A. .
ANNALS OF ONCOLOGY, 2006, 17 (07) :1141-1145
[39]   Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas [J].
Fischer, Lars ;
Hummel, Michael ;
Korfel, Agnieszka ;
Lenze, Dido ;
Joehrens, Korrina ;
Thiel, Eckhard .
NEURO-ONCOLOGY, 2011, 13 (10) :1090-1098
[40]   CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients [J].
Fischer, Lars ;
Korfel, Agnieszka ;
Pfeiffer, Sebastian ;
Kiewe, Philipp ;
Volk, Hans-Dieter ;
Cakiroglu, Huesniye ;
Widmann, Thomas ;
Thiel, Eckhard .
CLINICAL CANCER RESEARCH, 2009, 15 (19) :5968-5973